BAUDETTE, Minn., Oct. 27, 2014 /PRNewswire/ -- ANI
Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the
Company plans to release its third quarter and year-to-date 2014
financial results on Monday, November 3,
2014, before the opening of the U.S. financial markets. The
earnings press release will be accessible through the Investor
Relations section of the Company's website,
www.anipharmaceuticals.com.
Arthur S. Przybyl, President and
Chief Executive Officer, and Charlotte C.
Arnold, Vice President and Chief Financial Officer, also
plan to host a conference call to review those results starting at
10:30am, Eastern Time on Monday, November 3, 2014. The call will be open
to the public and can be accessed through a conference line by
dialing (855) 582-8078. The conference ID is 17132754.
A recording of the conference call will be available within two
hours of the completion of the call and will remain accessible for
a period of seven days following the call. To access the replay,
dial (855) 859-2056. The access code for the replay is
17132754.
About ANI
ANI Pharmaceuticals, Inc. (the "Company" or "ANI") is an
integrated specialty pharmaceutical company developing,
manufacturing, and marketing branded and generic prescription
pharmaceuticals. The Company's targeted areas of product
development currently include narcotics, oncolytics (anti-cancers),
hormones and steroids, and complex formulations involving extended
release and combination products. For more information, please
visit our website www.anipharmaceuticals.com.
For more information about ANI, please contact:
Investor Relations
(218) 634-3608
IR@anipharmaceuticals.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/ani-pharmaceuticals-schedules-conference-call-for-third-quarter-2014-financial-results-693989791.html
SOURCE ANI Pharmaceuticals